Akorn, Inc. Signs Definitive Commercial Manufacturing Supply Agreement With Advanced Vision Research, Inc.

BUFFALO GROVE, Ill.--(BUSINESS WIRE)--Aug. 7, 2006--Akorn, Inc. (AMEX:AKN - News) today announced that it has signed a Definitive Commercial Manufacturing Supply Agreement with Advanced Vision Research Inc. (AVR) for the product, TheraTears® lubricant eye drops. Akorn and Advanced Vision Research had previously announced the signing of a Term Sheet for the manufacture of TheraTears® on June 6, 2006. TheraTears® is a market leading over-the-counter ophthalmic solution for the treatment of dry eyes, and has recently been named by Drug Store News as the leading niche product in the eye care category.

Back to news